IL1B and breast carcinoma: (142) demonstrated that blockade of inflammasome-related IL-1β production and secretion attenuated cancer-associated thrombosis in a NETs-dependent breast cancer model, indicating the vital role of the crosstalk between NETs and inflammasomes in the treatment of breast cancer.